Continuous Passive Paracentesis for Intra-abdominal Hypertension (COPPTRIAHL)
Continuous Passive Paracentesis Versus Large Volume Paracentesis in the Prevention and Treatment of Intra-abdominal Hypertension and Abdominal Compartment Syndrome in the Critically Ill Cirrhotic Patient With Ascites
Sponsor: Centro Hospitalar de Lisboa Central
Listed as NCT04322201, this NA trial focuses on Ascites Hepatic and Cirrhosis, Liver and remains ongoing. Sponsored by Centro Hospitalar de Lisboa Central, it has been updated 6 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Nov 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centro Hospitalar de Lisboa Central
- NOVA Medical School
For direct contact, visit the study record on ClinicalTrials.gov .